Eden charges $199 a month for compounded tirzepatide and requires an Eden Membership on top, priced at $39 for the first month and $99 a month afterward. Shipping is free and expedited, a home injection kit is included, and the medication price does not change with dose. Laboratory testing is not listed as part of the plan.
Reviewed by Dr. Padra Nourparvar, DO, Regenerative Medicine
The entity behind the price list
Because more than one health business has used the Eden name, the pricing below should be tied to a specific seller. These figures come from the direct-to-consumer telehealth brand at tryeden.com, which now serves from eden.health and identifies Eden Health International in its legal footer. Prices published by any other Eden describe a different service entirely.
Line one: the medication charge
Compounded tirzepatide is listed at $199 a month. Compounded semaglutide sits at $99 a month on the same page. Both are described as medication only if prescribed, and both are compounded preparations rather than approved products, which Eden states directly in its footnotes.
The important qualifier attached to that $199 is the same price at every dose policy, which Eden describes as consistent pricing regardless of dosage adjustments through a program, excluding new member discounts and certain plans. Dose escalation is normal in tirzepatide treatment, so a flat medication rate removes a cost curve that many competitors keep. It is a real advantage and it deserves to be counted as one.
Line two: the membership, which is not optional
The membership is the line that reshapes the annual figure. It runs $39 for the first month and renews automatically at $99 a month. The published footnote is explicit that membership does not include or guarantee a prescription and that medication is not available without a membership. Terms describe the membership as covering provider consultations, secure messaging with a care team, prescription management where clinically appropriate, and access to educational content, with medication costs separate and disclosed at checkout.
Put together, month one is $238 and every month after is $298. A first year is $3,516 and a standing year is $3,576. The advertised $238 is accurate for exactly one billing cycle.
| Cost line | Eden’s published position | Effect on a twelve-month figure |
|---|---|---|
| Compounded tirzepatide | $199 per month, flat across doses | $2,388 across a year, stable |
| Eden Membership | $39 first month, $99 per month thereafter | $1,128 across a year, front-loaded discount |
| Shipping | Free expedited shipping on all orders | No addition |
| Injection supplies | Home injection kit included | No addition |
| Laboratory panel | Not listed in the plan description | Patient cost if a prescriber wants testing |
| Consultation | Initial telehealth consultation described as free | Absorbed into the membership rather than removed |
Set against that split structure, some sellers quote a single number instead. HealthRX lists compounded tirzepatide at one monthly rate with the consultation folded in, Ro and Hims and Hers publish their own bundled figures, Henry Meds leans on multi-month blocks, and manufacturer channels such as LillyDirect price the branded drug on a different tier altogether. None of that makes Eden’s two-line invoice wrong, but it is the reason a like-for-like annual total, rather than a headline, is the only figure that compares cleanly.
Line three: what is bundled and what quietly is not
Shipping is stated as free and expedited on all orders, and the tirzepatide product page states a home injection kit is included. The plan description covers a personalized treatment plan from a licensed provider, a custom dosing schedule, delivery through a state-licensed pharmacy and unlimited messaging with a care team. Doctor-led plans, coaching and community access appear on the product page as part of the offer.
Laboratory work is the visible gap. Eden’s published plan description does not include a bundled laboratory panel, so anyone whose prescriber wants baseline or follow-up testing will pay for it separately through insurance or a cash lab. That is common across compounded telehealth and it is not a hidden fee, but it belongs in a budget because current obesity pharmacotherapy guidance treats monitoring as part of treatment rather than an optional extra.
Line four: what Eden itself says brand access costs
The same page that lists compounded pricing quotes branded medication for comparison, at $1,399 a month for Ozempic, Zepbound and Mounjaro and $1,695 a month for Wegovy. Whatever those figures reflect in terms of access route, they make the trade explicit. The compounded rate is not a discount on the same product. Compounded tirzepatide has no FDA approval and the agency does not review such preparations for safety or effectiveness, while Zepbound carries approved indications for long-term weight reduction and maintenance and for moderate to severe obstructive sleep apnea in adults with obesity, and Mounjaro is approved for glycemic control in type 2 diabetes in adults and pediatric patients aged 10 and older.
Insurance rarely closes that gap. Medicare drug coverage has historically excluded products used for weight loss alone, which is a large part of why a cash market exists in the first place, and that exclusion follows the drug rather than the seller.
How to hold this price list against the rest of the market
The only fair comparison is total annual outlay at maintenance dose, with every recurring charge included. Some competitors bundle the consultation into one medication rate, some tier by milligram, and some discount heavily for prepaid blocks. Cross-provider breakdowns are a reasonable starting point for the checklist, and FormBlends is one cash-pay program that publishes running comparisons of competitor pricing structures alongside its own flat rates, though every figure taken from a rival’s page should be confirmed against the source provider’s current site before it enters a budget.
Eden also states there are no long-term contracts and that plans can be canceled at any time without a cancellation fee. That removes the prepaid-balance risk that some multi-month competitors carry, and it means the annual figure above is a running rate rather than a committed obligation.
Frequently asked questions
Why does the advertised monthly price differ across Eden’s pages?
Because different pages quote different components. The treatments page shows $199 for medication only, the tirzepatide product page shows $238 as medication plus the introductory membership, and the header promotion refers to compounded semaglutide at $99. All three are consistent with each other once the membership is separated out.
Does the medication price really stay flat at higher strengths?
That is the published policy, described as the same price at every dose and applied regardless of dosage adjustments during a program. Two carve-outs are named, new member discounts and specific plans, so a promotional plan may sit outside the guarantee. The policy is worth confirming at checkout for the exact plan being purchased.
Are the FSA and HSA claims worth anything in practice?
Eden marks its GLP-1 plans as FSA and HSA eligible, which can reduce the effective cost using pre-tax dollars. Eligibility depends on plan administrator rules and on documentation of medical necessity rather than on the seller’s label, so the claim is a starting point for a question to a benefits administrator rather than a guarantee.
Should the self-reported outcome figure influence a purchase?
Only lightly. Eden publishes an average of 29.3 pounds in six months based on self-reported data from 111 members, and labels it as such. Randomized evidence for the molecule, including SURMOUNT-1 and the SURMOUNT-4 maintenance trial, is a sounder basis for expectations than any provider’s voluntary sample.
What is the cheapest honest way to describe Eden’s price?
Roughly $298 a month at the standing rate, with a lower first month. Quoting $199 omits a mandatory charge, and quoting $238 describes one billing cycle. The standing combined figure is the number that should be compared against any other provider’s all-in monthly cost.
